البلد: إسرائيل
اللغة: الإنجليزية
المصدر: Ministry of Health
4 - AMINOSALICYLIC ACID
TRUEMED LTD, ISRAEL
J04AA01
GASTRO RESISTANT GRANULES
4 - AMINOSALICYLIC ACID 4 G/SACHET
PER OS
Required
EUROCEPT INTERNATIONAL B.V., THE NETHERLANDS
4-AMINOSALICYLIC ACID
GRANUPAS is indicated for use as part of an appropriate combination regimen for multi-drug resistant tuberculosis in adults and paediatric patients from 28 days of age and older when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
2023-09-30
.حتافلا ينبلا اهنول نم تابيبحلا تدقف اذإ وأ ً اخفتنم ناك اذإ سيكلا لمعتست لا ● .يعيبط اذه .كيدل زاربلا يف تابيبح دوجو ظحلات نأ زئاجلا نم ● ربكأ ً ايئاود ً ارادقم أطخلاب تلوانت اذإ بيبطلل ً لااح هجوت ،ءاودلا نم أطخلاب لفط علب اذإ وأ ً اطرفم ً ايئاود ً ارادقم تلوانت اذإ .ءاودلا ةبلع كعم رضحأو ىفشتسملا يف ئراوطلا ةفرغل وأ ءاودلا لوانت تيسن اذإ ىتح رظتنإ .يسنملا يئاودلا رادقملا نع ضيوعتلل ً افعاضم ً ايئاود ً ارادقم لوانتت لا .كب صاخلا يدايتعلإا يئاودلا رادقملا لوانت اهنيحو ،يلاتلا يئاودلا رادقملا دعوم .بيبطلا ةيصوت بسح جلاعلا ىلع ةبظاوملا بجي نم دكأتلاو ءاودلا عباط صيخشت بجي !ةمتعلا يف ةيودأ لوانت زوجي لا اذإ ةيبطلا تاراظنلا عض .ءاود اهيف لوانتت ةرم لك يف يئاودلا رادقملا .كلذ رملأا مزل بيبطلا رشتسإ ،ءاودلا اذه لامعتسإ لوح ةيفاضإ ةلئسأ كيدل ترفوت اذإ .يلديصلا وأ ةيبناجلا ضارعلأا )4 .نيلمعتسملا ضعب دنع ةيبناج ً اضارعأ ببسي دق ساپونارچ لامعتسإ نإ ،ءاود لكب امك .اهنم ً ايأ يناعت لاأ زئاجلا نم .ةيبناجلا ضارعلأا ةمئاق نم شهدنت لا لعف درل ةملاع لكل هابتنلإا كيلع ،ساپونارچ ـب جلاعلل ىلولأا ةثلاثلا رهشلأا للاخ ،حفط ،ةكح ،دلجلا حطس ىلع ةكاحو ءارمح طاقن ،ةيدلج ضارعأ ً لاثم( يسسحت ،قاهرإ ،ةنوخس ً لاثم( ] hepatitis [ دبكلا باهتلإ وأ )حشر وأ اقرأ الوثيقة كاملة
1 | P a g e 1. NAME OF THE MEDICINAL PRODUCT GRANUPAS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet contains 4 g of para-aminosalicylic acid. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Gastro-resistant granules The granules are small off white/ light brown coloured approximately 1.5 mm diameter. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS GRANUPAS is indicated for use as part of an appropriate combination regimen for multi-drug resistant tuberculosis in adults and paediatric patients from 28 days of age and older when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability. Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Adults_ 4 g (one sachet) three times per day. The recommended schedule is 4 g every 8 hours. GRANUPAS can be taken with food. Maximum daily dose is 12 g. Usual duration of treatment is 24 months. _Desensitization_ Desensitization can be accomplished by starting with 10 mg para-aminosalicylic acid (PAS) given as a single dose. The dosage is doubled every 2 days until reaching a total of 1 gram after which the dosage is divided to follow the regular schedule of administration. If a mild temperature rise or skin reaction develops, the increment is to be dropped back one level or the progression held for one cycle. Reactions are rare after a total dosage of 1.5 g. _Paediatric population_ The optimal dose regimen in children is uncertain. Limited pharmacokinetic data suggest no substantial difference between adults and children. For infants, children and adolescents the dosage will be adapted to the patient’s weight at 150 mg/kg 2 | P a g e per day, divided in two intakes. A dosing spoon is provided to measure small doses below 4 g for young children. The safety and efficacy of para-aminosalicylic acid in neonates have not been established. No data are available. Method of administration Oral use The conte اقرأ الوثيقة كاملة